Novartis slightly raises 2025 earnings forecast, citing strong Q2

• click to rate

  Posted by Two Blokes Jul 17 - Filed in Stock - 1 view
  
  Novartis on Thursday posted a slightly more optimistic full-year earnings forecast, citing the strong growth of drugs such as breast cancer drug Kisqali during the second quarter.